T1R and T2R receptors: The modulation of incretin hormones and potential targets for the treatment of type 2 diabetes mellitus

Current Opinion in Investigational Drugs

Volumn 11, Issue 4, 2010, Pages 447-454

  Dotson, Cedrick D ^a,b,c   Vigues, Stephan ^a   Steinle, Nanette I ^a   Munger, Steven D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Bitter; Enteroendocrine cell; Glucagon like peptide 1; Glucose dependent insulinotropic peptide; Sweet; Taste

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; INSULIN; NUCLEAR PROTEIN; T1R RECEPTOR; T2R RECEPTOR; UNCLASSIFIED DRUG;

DRUG TARGETING; GLUCOSE HOMEOSTASIS; GUSTATORY SYSTEM; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; TASTE BUD;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; INSULIN; RECEPTORS, G-PROTEIN-COUPLED;

EID: 77950112427     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. CDC: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. US Department of Health and Human Services, CDC, Atlanta, GA, USA (2008).
2. Kim W, Egan JM: The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev (2008) 60(4):470-512.
3. Verspohl EJ: Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors. Pharmacol Ther (2009) 124(1):113-138.
4. Gautier JF, Choukem SP, Girard J: Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab (2008) 34(Suppl 2):S65-S72.
5. Sternini C, Anselmi L, Rozengurt E: Enteroendocrine cells: A site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes (2008) 15(1):73-78.
6. Egan JM, Margolskee RF: Taste cells of the gut and gastrointestinal chemosensation. Mol Interv (2008) 8(2):78-81.
7. Brown JC, Mutt V, Pederson RA: Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol (1970) 209(1):57-64.
8. Schmidt WE, Siegel EG, Creutzfeldt W: Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia (1985) 28(9): 704-707.
9. Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK: Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab (2009) 10(2):99-109.
10. Zawalich WS: Synergistic impact of cholecystokinin and gastric inhibitory polypeptide on the regulation of insulin secretion. Metabolism (1988) 37(8):778-781.
11. Baggio LL, Drucker DJ: Biology of incretins: GLP-1 and GIP. Gastroenterology (2007) 132(6):2131-2157.
12. Shin YK, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, Jang HJ, Mattson MP, Drucker DJ, Egan JM, Munger SD: Modulation of taste sensitivity by GLP-1 signaling. J Neurochem (2008) 106(1):455-463.
13. Feng XH, Liu XM, Zhou LH, Wang J, Liu GD: Expression of glucagon-like peptide-1 in the taste buds of rat circumvallate papillae. Acta Histochem (2007) 110(2):151-154.
14. Martin B, Dotson CD, Shin YK, Ji S, Drucker DJ, Maudsley S, Munger SD: Modulation of taste sensitivity by GLP-1 signaling in taste buds. Ann N Y Acad Sci (2009) 1170:98-101.
15. Aulinger B, D'Alessio D: Glucagon-like peptide 1: Continued advances, new targets and expanding promise as a model therapeutic. Curr Opin Endocrinol Diabetes Obes (2007) 14(1): 68-73.
16. Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA: Glucagonlike peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology (2007) 148(10):4965-4973.
17. Drucker DJ: The biology of incretin hormones. Cell Metab (2006) 3(3):153-165.
18. Knop FK, Vilsboll T, Højberg PV, Larsen S, Madsbad S, Volund A, Holst JJ, Krarup T: Reduced incretin effect in type 2 diabetes: Cause or consequence of the diabetic state? Diabetes (2007) 56(8):1951-1959.
19. Nauck M, Stöckmann F, Ebert R, Creutzfeldt W: Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia (1986) 29(1):46-52.
20. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest (1993) 91(1):301-307.
21. Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA: Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagonlike peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulindependent) diabetic patients. J Clin Endocrinol Metab (1996) 81(1):327-332.
22. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP: Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem (1992) 267(11):7402-7405.
23. Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, Thogersen H, Wilken M, Agersø H: Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J Med Chem (2000) 43(9):1664-1669.
24. Kieffer TJ, McIntosh CH, Pederson RA: Degradation of glucosedependent insulinotropic polypeptide and truncated glucagonlike peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology (1995) 136(8):3585-3596.
25. Mentlein R, Gallwitz B, Schmidt WE: Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagonlike peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem (1993) 214(3):829-835.
26. Information for Healthcare Professionals: Reports of Altered Kidney Function in patients using Exenatide (Marketed as Byetta): US FDA, Silver Spring, MD, USA (2009). www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm188656.htm
27. Information for Healthcare Professionals: Exenatide (marketed as Byetta) - 8/2008 Update: US FDA, Silver Spring, MD, USA (2008). www.fda.gov/Drugs/ DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ ucm124713.htm
28. Chandrashekar J, Hoon MA, Ryba NJ, Zuker CS: The receptors and cells for mammalian taste. Nature (2006) 444(7117):288-294.
29. Bachmanov AA, Beauchamp GK: Taste receptor genes. Annu Rev Nutr (2007) 27:389-414.
30. Vigues S, Dotson CD, Munger SD: The receptor basis of sweet taste in mammals. In: Chemosensory Systems in Mammals, Fishes, and Insects. Meyerhof W, Korsching S (Eds), Springer Berlin/Heidelberg, Berlin, Germany (2009) 47:187-202.
31. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, Zuker CS: Mammalian sweet taste receptors. Cell (2001) 106(3):381-390.
32. Li X, Staszewski L, Xu H, Durick K, Zoller M, Adler E: Human receptors for sweet and umami taste. Proc Natl Acad Sci USA (2002) 99(7):4692-4696.
33. Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, Ryba NJ, Zuker CS: The receptors for mammalian sweet and umami taste. Cell (2003) 115(3):255-266.
34. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJ, Zuker CS: An amino-acid taste receptor. Nature (2002) 416(6877):199-202.
35. Behrens M, Meyerhof W: Mammalian bitter taste perception. In: Chemosensory Systems in Mammals, Fishes, and Insects. Meyerhof W, Korsching S (Eds), Springer Berlin/Heidelberg, Berlin, Germany (2009) 47:203-220.
36. Chandrashekar J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, Zuker CS, Ryba NJ: T2Rs function as bitter taste receptors. Cell (2000) 100(6):703-711.
37. Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, Appendino G, Behrens M: The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses (2010) 35(2):157-170.
38. Sugita M: Taste perception and coding in the periphery. Cell Mol Life Sci (2006) 63(17):2000-2015.
39. McLaughlin SK, McKinnon PJ, Margolskee RF: Gustducin is a taste-cell-specific G protein closely related to the transducins. Nature (1992) 357(6379):563-569.
40. Wong GT, Gannon KS, Margolskee RF: Transduction of bitter and sweet taste by gustducin. Nature (1996) 381(6585): 796-800.
41. Zhang Y, Hoon MA, Chandrashekar J, Mueller KL, Cook B, Wu D, Zuker CS, Ryba NJ: Coding of sweet, bitter, and umami tastes: Different receptor cells sharing similar signaling pathways. Cell (2003) 112(3):293-301.
42. Clapp TR, Stone LM, Margolskee RF, Kinnamon SC: Immunocytochemical evidence for co-expression of Type III IP3 receptor with signaling components of bitter taste transduction. BMC Neurosci (2001) 2:6.
43. Hisatsune C, Yasumatsu K, Takahashi-Iwanaga H, Ogawa N, Kuroda Y, Yoshida R, Ninomiya Y, Mikoshiba K: Abnormal taste perception in mice lacking the type 3 inositol 1,4,5- trisphosphate receptor. J Biol Chem (2007) 282(51):37225-37231.
44. Perez CA, Huang L, Rong M, Kozak JA, Preuss AK, Zhang H, Max M, Margolskee RF: A transient receptor potential channel expressed in taste receptor cells. Nat Neurosci (2002) 5(11): 1169-1176.
45. Nakagawa Y, Nagasawa M, Yamada S, Hara A, Mogami H, Nikolaev VO, Lohse MJ, Shigemura N, Ninomiya Y, Kojima I: Sweet taste receptor expressed in pancreatic β-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS One (2009) 4(4):e5106.
46. Taniguchi K: Expression of the sweet receptor protein, T1R3, in the human liver and pancreas. J Vet Med Sci (2004) 66(11): 1311-1314.
47. Ren X, Zhou L, Terwilliger R, Newton SS, de Araujo IE: Sweet taste signaling functions as a hypothalamic glucose sensor. Front Integr Neurosci (2009) 3:12.
48. Finger TE, Bottger B, Hansen A, Anderson KT, Alimohammadi H, Silver WL: Solitary chemoreceptor cells in the nasal cavity serve as sentinels of respiration. Proc Natl Acad Sci USA (2003) 100(15):8981-8986.
49. Gulbransen BD, Clapp TR, Finger TE, Kinnamon SC: Nasal solitary chemoreceptor cell responses to bitter and trigeminal stimulants in vitro. J Neurophysiol (2008) 99(6):2929-2937.
50. Shah AS, Ben-Shahar Y, Moninger TO, Kline JN, Welsh MJ: Motile cilia of human airway epithelia are chemosensory. Science (2009) 325(5944):1131-1134.
51. Hofer D, Puschel B, Drenckhahn D: Taste receptor-like cells in the rat gut identified by expression of a-gustducin. Proc Natl Acad Sci USA (1996) 93(13):6631-6634.
52. Wu SV, Rozengurt N, Yang M, Young SH, Sinnett-Smith J, Rozengurt E: Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proc Natl Acad Sci USA (2002) 99(4):2392-2397.
53. Dyer J, Salmon KS, Zibrik L, Shirazi-Beechey SP: Expression of sweet taste receptors of the T1R family in the intestinal tract and enteroendocrine cells. Biochem Soc Trans (2005) 33 (Pt 1):302-305.
54. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, Kim HH, Xu X, Chan SL, Juhaszova M, Bernier M et al: Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA (2007) 104(38):15069-15074.
55. Margolskee RF, Dyer J, Kokrashvili Z, Salmon KS, Ilegems E, Daly K, Maillet EL, Ninomiya Y, Mosinger B, Shirazi-Beechey SP: T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci USA (2007) 104(38):15075-15080.
56. Mace OJ, Affleck J, Patel N, Kellett GL: Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2. J Physiol (2007) 582(Pt 1):379-392.
57. Bezencon C, le Coutre J, Damak S: Taste-signaling proteins are coexpressed in solitary intestinal epithelial cells. Chem Senses (2007) 32(1):41-49.
58. Dotson CD, Zhang L, Xu H, Shin Y-K, Vigues S, Ott SH, Elson AET, Choi H-J, Shaw H, Egan JM, Mitchell BD et al: Bitter taste receptors influence glucose homeostasis. PLoS ONE (2008) 3(12):e3974.
59. Jeon TI, Zhu B, Larson JL, Osborne TF: SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice. J Clin Invest (2008) 118(11):3693-3700.
60. Rozengurt N, Wu SV, Chen MC, Huang C, Sternini C, Rozengurt E: Colocalization of the α-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol (2006) 291(5):G792-G802.
61. Sutherland K, Young RL, Cooper NJ, Horowitz M, Blackshaw LA: Phenotypic characterization of taste cells of the mouse small intestine. Am J Physiol Gastrointest Liver Physiol (2007) 292(5):G1420-G1428.
62. Galindo-Cuspinera V, Winnig M, Bufe B, Meyerhof W, Breslin PA: A TAS1R receptor-based explanation of sweet 'water-taste'. Nature (2006) 441(7091):354-357.
63. Xu H, Staszewski L, Tang H, Adler E, Zoller M, Li X: Different functional roles of T1R subunits in the heteromeric taste receptors. Proc Natl Acad Sci USA (2004) 101(39):14258-14263.
64. Chen MC, Wu SV, Reeve JR Jr, Rozengurt E: Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: Role of L-type voltage-sensitive Ca2+ channels. Am J Physiol Cell Physiol (2006) 291(4):C726-C739.
65. Maehashi K, Huang L: Bitter peptides and bitter taste receptors. Cell Mol Life Sci (2009) 66(10):1661-1671.
66. Mace OJ, Lister N, Morgan E, Shepherd E, Affleck J, Helliwell P, Bronk JR, Kellett GL, Meredith D, Boyd R, Pieri M et al: An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine. J Physiol (2009) 587(Pt 1):195-210.
67. Fujita Y, Wideman RD, Speck M, Asadi A, King DS, Webber TD, Haneda M, Kieffer TJ: Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab (2009) 296(3):E473-E479.
68. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK: Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol (2009) 296(4):G735-G739.
69. Grotz VL, Henry RR, McGill JB, Prince MJ, Shamoon H, Trout JR, Pi-Sunyer FX: Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc (2003) 103(12):1607-1612.
70. Hayashi Y, Yamamoto M, Mizoguchi H, Watanabe C, Ito R, Yamamoto S, Sun XY, Murata Y: Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet α-cells but not of intestinal L-cells. Mol Endocrinol (2009) 23(12):1990-1999.
71. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med (1996) 2(11):1254-1258.
72. Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ, Steiner DF: Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA (2002) 99(16):10293-10298.
73. Ugleholdt R, Zhu X, Deacon CF, Orskov C, Steiner DF, Holst JJ: Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1. Endocrinology (2004) 145(3): 1349-1355.
74. Nie Y, Vigues S, Hobbs JR, Conn GL, Munger SD: Distinct contributions of T1R2 and T1R3 taste receptor subunits to the detection of sweet stimuli. Curr Biol (2005) 15(21): 1948-1952.
75. Assadi-Porter FM, Tonelli M, Maillet E, Hallenga K, Benard O, Max M, Markley JL: Direct NMR detection of the binding of functional ligands to the human sweet receptor, a heterodimeric family 3 GPCR. J Am Chem Soc (2008) 130(23): 7212-7213.
76. Senomyx Inc (Tachdjian C, Li X, Qi M, Rinnova M, Servant G, Zoller M): Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof. US-07476399 (2009).
77. Senomyx Inc (Li X, Xu H, Tang H, Li Q): Human T2R receptors for acetaminophen ranitidine, strychnine and denatomium and related assays for identifying human bitter taste modulators. US-07407765 (2008).
78. Senomyx Inc (Adler J, Li X, Staszewski L, Xu H, Echeverri F): Methods of screening compounds using a T1R3 heterooligomeric taste receptor. US-07419791 (2008).
79. Zhang F, Klebansky B, Fine RM, Liu H, Xu H, Servant G, Zoller M, Tachdjian C, Li X: Molecular mechanism of the sweet taste enhancers. Proc Natl Acad Sci USA 107(10):4752-4757.
80. Servant G, Tachdjian C, Tang XQ, Werner S, Zhang F, Li X, Kamdar P, Petrovic G, Ditschun T, Java A, Brust P et al: Positive allosteric modulators of the human sweet taste receptor enhance sweet taste. Proc Natl Acad Sci USA 107(10):4746-4751.
81. Jiang P, Cui M, Zhao B, Snyder LA, Benard LM, Osman R, Max M, Margolskee RF: Identification of the cyclamate interaction site within the transmembrane domain of the human sweet taste receptor subunit T1R3. J Biol Chem (2005) 280(40):34296-34305.
82. Winnig M, Bufe B, Kratochwil NA, Slack JP, Meyerhof W: The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor. BMC Struct Biol (2007) 7:66.
83. Winnig M, Bufe B, Meyerhof W: Valine 738 and lysine 735 in the fifth transmembrane domain of rTas1r3 mediate insensitivity towards lactisole of the rat sweet taste receptor. BMC Neurosci (2005) 6(1):22.